Name:
Burkholderia cenocepacia Vandamme et al. 2003
DSM No.:
16553, Type strain dsm-16553 dsm16553 dsm 16553 Burkholderia cenocepacia
Strain designation:
CF5610, J2315
Other collection no.
or WDCM no.:
LMG 16656,ATCC BAA-245,CCM 4899,CCUG 48434,NCTC 13227
Isolated from:
sputum from cystic fibrosis patient
Country:
United Kingdom of Great Britain and Northern Ireland
Edinburgh
Date of sampling:
before 2004-04-12
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- LMG; LMG 16656 <- J. Govan; CF5610
Genbank accession numbers:
Pathogen traits:
multiresistant
Summary and
additional information:
<- LMG; LMG 16656 <- J. Govan; CF5610. Sputum from cystic fibrosis patient. United Kingdom of Great Britain and Northern Ireland, Edinburgh. Type strain.. Taxonomy/description (6983, 8941, 8959). Sequence accession no. 16S rRNA gene: AF148556, chromosome 1, complete sequence: AM747720. (Medium 92, incubation time: 1-2 days, pH 7, 30°C, aerobic or Medium 693, incubation time: 1-2 days, pH 7, 30°C, aerobic)
Risk group:
2 (classification according to German
TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz),
Category A1
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 120,- € |
| Active culture on request | | 280,- € |
| DNA | | 180,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.Note: Freight charges for Risk Group 2 microorganisms will apply.
